Synbio Tech Inc. (TPEX:1295)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
93.70
-1.20 (-1.26%)
At close: Dec 5, 2025
18.76%
Market Cap 3.23B
Revenue (ttm) 1.00B
Net Income (ttm) 155.61M
Shares Out 34.48M
EPS (ttm) 4.77
PE Ratio 19.63
Forward PE 12.72
Dividend 3.50 (3.69%)
Ex-Dividend Date Mar 27, 2025
Volume 86,511
Average Volume 156,230
Open 95.00
Previous Close 94.90
Day's Range 93.60 - 95.00
52-Week Range 58.50 - 157.50
Beta n/a
RSI 37.88
Earnings Date Nov 7, 2025

About Synbio Tech

Synbio Tech Inc. manufactures and sells human healthcare products and probiotics for animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. The company also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improve digestive and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 92
Stock Exchange Taipei Exchange
Ticker Symbol 1295
Full Company Profile

Financial Performance

In 2024, Synbio Tech's revenue was 989.48 million, an increase of 20.18% compared to the previous year's 823.30 million. Earnings were 170.13 million, an increase of 50.19%.

Financial Statements

News

There is no news available yet.